Metrics

Metrics

Studies (up to 30 April 2019)

The total number of studies listed on this site is 3722.

Research Proposals requesting access to patient level data (up to 31 March 2019)

A summary of the number of Research Proposals received via this site since May 2013 is provided here and is updated monthly.

The table below provides metrics for different parts of the process following submission of a Research Proposal (Requirements check, Independent Review Panel (IRP) review, Data Sharing Agreement, Data preparation, Data Access and Publication). The "In process" rows provide the number of Research Proposals in this part of the process. The other rows for each part of the process provide the total number of Research Proposals that have achieved that outcome.

Number of Research Proposals submitted up to 31 March 2019 494
Requirements check In process 34
Withdrawn by the requestor 46
No response received 17
Did not meet requirements (further details) 18
Potential conflict of interest or an actual or potential competitive risk 0
Met requirements 379
IRP review In process 3
Withdrawn by the requestor 4
No response received 2
Rejected or advised to re-submit 57
Approved or approved with conditions 313
Data Sharing Agreement In process 46
Withdrawn by the requestor 13
No response received 5
Not agreed by requestor 1
Agreed (signed) View details of these Research Proposals 248
Data preparation In process 6
Withdrawn by the requestor 1
No response received 2
Complete (data available) 239
Data Access Access provided 133
Withdrawn by the requestor 1
Access closed 105
Publication
Publication anticipated 32
Published
View details of these Research Proposals
42
Withdrawn by requestor 13
No response received 17
Publication not received after 18 months of Access Closed 4

Multi-Sponsor Research Proposals were possible starting 1 January 2014. Out of 472 proposals submitted since 1 January 2014, 81 were multi-Sponsor proposals.

Enquiries related to non-listed studies (up to 31 March 2019)

A summary of the number of Enquiries received via this site since May 2013 is provided here and is updated every 3 months.

The table below provides information on the number of non-listed studies for which Enquiries were received via ClinicalStudyDataRequest.com. Enquiries received outside the system, general Enquiries not related to accessing patient level data, Enquiries requesting access to documents only and Enquiries for specific data points are not included in these metrics.

Study Sponsor/Funder Number of non-listed studies requested Number of studies undergoing feasibility assessments Number of studies with a positive response1 Number of studies with a negative response2
Astellas 59 10 9 40 (further details)
Boehringer Ingelheim 74 0 43 31 (further details)
Daiichi Sankyo 2 1 0 2 (further details)
Eisai 67 0 6 61 (further details)
GSK 215 0 172 43 (further details)
Lilly 93 0 88 105 (further details)
Novartis 253 11 69 173 (further details)
Roche1 209 50 42 117 (further details)
Sanofi 96 2 23 71 (further details)
Takeda 100 0 23 77 (further details)
UCB 40 6 28 12 (further details)
ViiV Healthcare 6 0 6 0

1 Study to be listed on ClinicalStudyDataRequest.com and researcher able to submit a Research Proposal, or access to the requested data is otherwise enabled.

2 Study will not be listed on ClinicalStudyDataRequest.com / access to data cannot be provided.